CS logo
small CS logo
Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)

Milan, Italy
Hospital department in Milan
Piazza dell'Ospedale Maggiore, 3, 20162 Milano MI

About Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)


"Il Centro Clinico NeMO Milano (NEuroMuscular Omnicentre) è un Centro Clinico ad alta specializzazione, pensato per rispondere in modo specifico alle necessità di chi è affetto da malattie neuromuscolari come la SLA , la SMA e le distrofie muscolari. Lo scopo è migliorare la qualità di vita delle persone prese in carico, fornendo loro e alle famiglie un supporto clinico, assistenziale e psicologico che risponda ai bisogni globali. Realtà viva e vitale sul territorio, negli anni il NeMO ha dimostrato di essere un progetto replicabile. Un modello di sanità unico dove tutto ruota attorno al malato e alla sua famiglia."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)


During the past decade, Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)


According to Clinical.Site data, the most researched conditions in "Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)" are "ALS" (2 trials) and "Amyotrophic Lateral Sclerosis (ALS)" (1 trials). Many other conditions were trialed in "Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)" in a lesser frequency.

Clinical Trials Intervention Types at Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)


Most popular intervention types in "Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "MT-1186" (3 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)


The vast majority of trials in "Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)" are 3 trials for "All" genders.

Clinical Trials Status at Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)


Currently, there are NaN active trials in "Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre)". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".